Primary Site >> Colorectal Cancer

Gene >> ABCG2

Journal: Cancer Res. 1999 Jan 1;59(1):8-13.
Title: Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.
Author: Miyake, K|Mickley, L|Litman, T|Zhan, Z|Robey, R|Cristensen, B|Brangi, M|Greenberger, L|Dean, M|Fojo, T|Bates, S E
PMID: 9892175
Journal: J Natl Cancer Inst. 1999 Mar 3;91(5):429-33.
Title: Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.
Author: Ross, D D|Yang, W|Abruzzo, L V|Dalton, W S|Schneider, E|Lage, H|Dietel, M|Greenberger, L|Cole, S P|Doyle, L A
PMID: 10070941
Journal: Cancer Res. 1999 Dec 1;59(23):5938-46.
Title: Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.
Author: Brangi, M|Litman, T|Ciotti, M|Nishiyama, K|Kohlhagen, G|Takimoto, C|Robey, R|Pommier, Y|Fojo, T|Bates, S E
PMID: 10606239
Journal: Cancer Res. 2001 Jan 15;61(2):739-48.
Title: The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.
Author: Erlichman, C|Boerner, S A|Hallgren, C G|Spieker, R|Wang, X Y|James, C D|Scheffer, G L|Maliepaard, M|Ross, D D|Bible, K C|Kaufmann, S H
PMID: 11212277
Journal: Cancer Res. 2001 Apr 1;61(7):2827-32.
Title: Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure.
Author: Komatani, H|Kotani, H|Hara, Y|Nakagawa, R|Matsumoto, M|Arakawa, H|Nishimura, S
PMID: 11306452
Journal: Mol Pharmacol. 2003 Aug;64(2):279-88.
Title: Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistance.
Author: Wierdl, Monika|Wall, Amelia|Morton, Christopher L|Sampath, Janardhan|Danks, Mary K|Schuetz, John D|Potter, Philip M
PMID: 12869632
Journal: Biochem Pharmacol. 2004 Mar 15;67(6):1035-45.
Title: Subcellular localization of the camptothecin analogues, topotecan and gimatecan.
Author: Croce, Anna Cleta|Bottiroli, Giovanni|Supino, Rosanna|Favini, Enrica|Zuco, Valentina|Zunino, Franco
PMID: 15006540
Journal: Int J Cancer. 2004 May 10;109(6):848-54.
Title: ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases.
Author: Candeil, Laurent|Gourdier, Isabelle|Peyron, Delphine|Vezzio, Nadia|Copois, Virginie|Bibeau, Frederic|Orsetti, Beatrice|Scheffer, George L|Ychou, Marc|Khan, Qasim A|Pommier, Yves|Pau, Bernard|Martineau, Pierre|Del Rio, Maguy
PMID: 15027118
Journal: Mol Cancer Ther. 2004 Sep;3(9):1119-25.
Title: Gefitinib reverses breast cancer resistance protein-mediated drug resistance.
Author: Yanase, Kae|Tsukahara, Satomi|Asada, Sakiyo|Ishikawa, Etsuko|Imai, Yasuo|Sugimoto, Yoshikazu
PMID: 15367706
Journal: Clin Colorectal Cancer. 2004 Sep;4(3):163-80.
Title: Topoisomerase I inhibitors in the treatment of gastrointestinal cancer: from intravenous to oral administration.
Author: Kuppens, Isa E L M|Beijnen, Jos|Schellens, Jan H M
PMID: 15377400
Journal: Br J Cancer. 2005 Jan 31;92(2):259-64.
Title: Unfavourable expression of pharmacologic markers in mucinous colorectal cancer.
Author: Glasgow, S C|Yu, J|Carvalho, L P|Shannon, W D|Fleshman, J W|McLeod, H L
PMID: 15655543
Journal: Anticancer Res. 2005 Jul-Aug;25(4):2661-8.
Title: Gene expression profiling in chemoresistant variants of three cell lines of different origin.
Author: Johnsson, Anders|Vallon-Christensson, Johan|Strand, Carina|Litman, Thomas|Eriksen, Jens
PMID: 16080509
Journal: Anticancer Drugs. 2005 Nov;16(10):1099-108.
Title: The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan.
Author: Braun, Ada Henrike|Stark, Katrin|Dirsch, Olaf|Hilger, Ralf Axel|Seeber, Siegfried|Vanhoefer, Udo
PMID: 16222152
Journal: J Med Chem. 2005 Nov 17;48(23):7275-81.
Title: Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2).
Author: Boumendjel, Ahcene|Nicolle, Edwige|Moraux, Thomas|Gerby, Bastien|Blanc, Madeleine|Ronot, Xavier|Boutonnat, Jean
PMID: 16279786
Journal: Cancer Lett. 2006 Mar 8;234(1):90-106.
Title: Role of pharmacogenetics in irinotecan therapy.
Author: de Jong, Floris A|de Jonge, Maja J A|Verweij, Jaap|Mathijssen, Ron H J
PMID: 16343744
Journal: Eur J Pharmacol. 2006 Feb 15;531(1-3):25-33.
Title: Modulation of p-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids.
Author: Cooray, Hiran C|Shahi, Sanjay|Cahn, Anthony P|van Veen, Hendrik W|Hladky, Stephen B|Barrand, Margery A
PMID: 16442095
Journal: Invest New Drugs. 2006 Sep;24(5):393-401.
Title: Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes.
Author: Zamboni, William C|Ramanathan, Ramesh K|McLeod, Howard L|Mani, Sridhar|Potter, Douglas M|Strychor, Sandra|Maruca, Lauren J|King, Cristi R|Jung, Laura L|Parise, Robert A|Egorin, Merrill J|Davis, Todd A|Marsh, Sharon
PMID: 16505951
Journal: Biochem Biophys Res Commun. 2006 May 5;343(2):571-7. Epub 2006 Mar 9.
Title: Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer.
Author: Gupta, Naren|Martin, Pamela M|Miyauchi, Seiji|Ananth, Sudha|Herdman, Anne V|Martindale, Robert G|Podolsky, Robert|Ganapathy, Vadivel
PMID: 16554028
Journal: World J Gastroenterol. 2006 Aug 28;12(32):5140-7.
Title: Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib (Iressa(TM)) and to the antiangiogenic agent ZD6474: Cytotoxic and biomolecular effects.
Author: Azzariti, Amalia|Porcelli, Letizia|Xu, Jian-Ming|Simone, Grazia Maria|Paradiso, Angelo
PMID: 16937523
Journal: Cancer Res. 2008 Apr 1;68(7):2292-300.
Title: TTI-237: a novel microtubule-active compound with in vivo antitumor activity.
Author: Beyer, Carl F|Zhang, Nan|Hernandez, Richard|Vitale, Danielle|Lucas, Judy|Nguyen, Thai|Discafani, Carolyn|Ayral-Kaloustian, Semiramis|Gibbons, James J
PMID: 18381436
Journal: Br J Cancer. 2008 May 6;98(9):1515-24.
Title: Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes.
Author: Calcagno, A M|Fostel, J M|To, K K W|Salcido, C D|Martin, S E|Chewning, K J|Wu, C-P|Varticovski, L|Bates, S E|Caplen, N J|Ambudkar, S V
PMID: 18382425
Journal: Mol Cell Biol. 2008 Sep;28(17):5147-61.
Title: Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.
Author: To, Kenneth K W|Zhan, Zhirong|Litman, Thomas|Bates, Susan E
PMID: 18573883
Journal: Int J Cancer. 2008 Oct 1;123(7):1712-20.
Title: Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco-2 cells.
Author: Lemos, Clara|Kathmann, Ietje|Giovannetti, Elisa|Dekker, Henk|Scheffer, George L|Calhau, Conceicao|Jansen, Gerrit|Peters, Godefridus J
PMID: 18623116
Journal: Mutat Res. 2008 Oct 14;645(1-2):56-60.
Title: A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer.
Author: Campa, Daniele|Pardini, Barbara|Naccarati, Alessio|Vodickova, Ludmila|Novotny, Jan|Forsti, Asta|Hemminki, Kari|Barale, Roberto|Vodicka, Pavel|Canzian, Federico
PMID: 18775442
Journal: Basic Clin Pharmacol Toxicol. 2008 Oct;103(4):336-41.
Title: Antipsychotic drugs inhibit the function of breast cancer resistance protein.
Author: Wang, Jun-Sheng|Zhu, Hao-Jie|Markowitz, John S|Donovan, Jennifer L|Yuan, Hong-Jie|Devane, C Lindsay
PMID: 18834354
Journal: Br J Cancer. 2009 Apr 7;100(7):1120-7.
Title: Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib.
Author: Lemos, C|Kathmann, I|Giovannetti, E|Calhau, C|Jansen, G|Peters, G J
PMID: 19277036
Journal: Eur J Pharm Sci. 2009 Jun 28;37(3-4):463-8.
Title: Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513.
Author: Salphati, Laurent|Plise, Emile G|Li, Guangmin
PMID: 19491037
Journal: Biochem Pharmacol. 2009 Dec 1;78(11):1366-73.
Title: Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy.
Author: Theile, Dirk|Grebhardt, Sina|Haefeli, Walter Emil|Weiss, Johanna
PMID: 19622348
Journal: Ai Zheng. 2009 Sep;28(9):932-8.
Title: [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Author: Yuan, Shu-Qiang|Zhou, Zhi-Wei|Liang, Yong-Ju|Fu, Li-Wu|Chen, Gong|Qiu, Hai-Bo|Zhang, Li-Yi
PMID: 19728910
Journal: BMC Cancer. 2009 Nov 21;9:407.
Title: Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study.
Author: Andersen, Vibeke|Ostergaard, Mette|Christensen, Jane|Overvad, Kim|Tjonneland, Anne|Vogel, Ulla
PMID: 19930591
Journal: Photochem Photobiol Sci. 2009 Dec;8(12):1716-23.
Title: Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.
Author: Jendzelovsky, Rastislav|Mikes, Jaromir|Koval', Jan|Soucek, Karel|Prochazkova, Jirina|Kello, Martin|Sackova, Veronika|Hofmanova, Jirina|Kozubik, Alois|Fedorocko, Peter
PMID: 20024169
Journal: Oncol Rep. 2010 Jan;23(1):191-7.
Title: CpG island methylation of BNIP3 predicts resistance against S-1/CPT-11 combined therapy in colorectal cancer patients.
Author: Hiraki, Masatsugu|Kitajima, Yoshihiko|Nakafusa, Yuji|Nakamura, Jun|Hashiguchi, Kazuyoshi|Sumi, Kenji|Noshiro, Hirokazu|Miyazaki, Kohji
PMID: 19956881
Journal: Carcinogenesis. 2010 Jun;31(6):1003-9.
Title: Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers.
Author: Ku, Ja-Lok|Shin, Young-Kyoung|Kim, Duck-Woo|Kim, Kyung-Hee|Choi, Jin-Sung|Hong, Sung-Hye|Jeon, You-Kyung|Kim, Sung-Hee|Kim, Hong-Sun|Park, Jae-Hyun|Kim, Il-Jin|Park, Jae-Gahb
PMID: 20176655
Journal: Biochem Pharmacol. 2010 Aug 15;80(4):471-9.
Title: Chrysin blocks topotecan-induced apoptosis in Caco-2 cells in spite of inhibition of ABC-transporters.
Author: Schumacher, Marco|Hautzinger, Anja|Rossmann, Annette|Holzhauser, Susanne|Popovic, Daniela|Hertrampf, Anke|Kuntz, Sabine|Boll, Michael|Wenzel, Uwe
PMID: 20457140
Journal: Mol Pharmacol. 2010 Aug;78(2):175-85.
Title: Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2).
Author: Tan, Kah Poh|Wang, Bernice|Yang, Mingdong|Boutros, Paul C|Macaulay, Jane|Xu, Haibo|Chuang, Andrew I|Kosuge, Kazuhiro|Yamamoto, Mika|Takahashi, Shinichiro|Wu, Alex M L|Ross, Douglas D|Harper, Patricia A|Ito, Shinya
PMID: 20460431
Journal: Anticancer Res. 2010 Jun;30(6):2041-8.
Title: Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells.
Author: Chikazawa, Nobuhito|Tanaka, Haruo|Tasaka, Takehiko|Nakamura, Masafumi|Tanaka, Masao|Onishi, Hideya|Katano, Mitsuo
PMID: 20651349
Journal: Asian Pac J Cancer Prev. 2010;11(4):845-8.
Title: Expression of ABCG2 and its significance in colorectal cancer.
Author: Liu, Hai Guang|Pan, Yi Fei|You, Jie|Wang, Ou Chen|Huang, Ka Te|Zhang, Xiao Hua
PMID: 21133588
Journal: Pharm Res. 2011 Apr;28(4):827-38.
Title: Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells.
Author: Kanwar, Shailender Singh|Yu, Yingjie|Nautiyal, Jyoti|Patel, Bhaumik B|Padhye, Subhash|Sarkar, Fazlul H|Majumdar, Adhip P N
PMID: 21161336
Journal: Int J Cancer. 2011 Aug 1;129(3):546-52.
Title: Downregulation of breast cancer resistance protein in colon adenomas reduces cellular xenobiotic resistance and leads to accumulation of a food-derived carcinogen.
Author: Dietrich, Christoph G|Vehr, Ann-Kathrin|Martin, Ina V|Gassler, Nikolaus|Rath, Timo|Roeb, Elke|Schmitt, Johannes|Trautwein, Christian|Geier, Andreas
PMID: 21544799
Journal: Biochem Biophys Res Commun. 2011 May 27;409(1):75-81.
Title: Induction of apoptosis in colon cancer cells by a novel topoisomerase I inhibitor TopIn.
Author: Bae, Soo Kyung|Gwak, Jungsug|Song, Im-Sook|Park, Hyung-Soon|Oh, Sangtaek
PMID: 21549095
Journal: Mol Cancer Ther. 2011 Jul;10(7):1252-63.
Title: Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
Author: Yamazaki, Ryuta|Nishiyama, Yukiko|Furuta, Tomio|Hatano, Hiroshi|Igarashi, Yoshiaki|Asakawa, Naoyuki|Kodaira, Hiroshi|Takahashi, Hiroyuki|Aiyama, Ritsuo|Matsuzaki, Takeshi|Yagi, Nao|Sugimoto, Yoshikazu
PMID: 21566063
Journal: Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G347-55.
Title: Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
Author: Oh, Phil-Sun|Patel, Vaishali B|Sanders, Matthew A|Kanwar, Shailender S|Yu, Yingjie|Nautiyal, Jyoti|Patel, Bhaumik B|Majumdar, Adhip P N
PMID: 21596996
Journal: Am J Physiol Cell Physiol. 2011 Nov;301(5):C984-94.
Title: The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein.
Author: Goncalves, Pedro|Gregorio, Ines|Martel, Fatima
PMID: 21775706
Journal: Eur J Pharmacol. 2011 Nov 16;670(1):74-84.
Title: MC70 potentiates doxorubicin efficacy in colon and breast cancer in vitro treatment.
Author: Azzariti, Amalia|Quatrale, Anna E|Porcelli, Letizia|Colabufo, Nicola A|Cantore, Mariangela|Cassano, Giuseppe|Gasparre, Giuseppe|Iannelli, Giuseppina|Tommasi, Stefania|Panaro, Maria A|Paradiso, Angelo
PMID: 21925160
Journal: PLoS Comput Biol. 2011 Sep;7(9):e1002143.
Title: A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery.
Author: Ballesta, Annabelle|Dulong, Sandrine|Abbara, Chadi|Cohen, Boris|Okyar, Alper|Clairambault, Jean|Levi, Francis
PMID: 21931543
Journal: Biol Pharm Bull. 2011;34(10):1624-7.
Title: Coffee induces breast cancer resistance protein expression in Caco-2 cells.
Author: Isshiki, Marina|Umezawa, Kazuo|Tamura, Hiroomi
PMID: 21963506
Journal: Cancers (Basel). 2011 Mar 22;3(1):1467-79.
Title: Overexpression of CYP3A4 in a COLO 205 Colon Cancer Stem Cell Model in vitro.
Author: Olszewski, Ulrike|Liedauer, Richard|Ausch, Christoph|Thalhammer, Theresia|Hamilton, Gerhard
PMID: 24212669
Journal: Chin J Cancer. 2012 Mar;31(3):150-8.
Title: ABCG2-overexpressing S1-M1-80 cell xenografts in nude mice keep original biochemistry and cell biological properties.
Author: Wang, Fang|Liang, Yong-Ju|Wu, Xing-Ping|Su, Xiao-Dong|Fu, Li-Wu
PMID: 22360854
Journal: Br J Cancer. 2012 Mar 27;106(7):1320-30.
Title: MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.
Author: Xu, X T|Xu, Q|Tong, J L|Zhu, M M|Nie, F|Chen, X|Xiao, S D|Ran, Z H
PMID: 22453125
Journal: Nan Fang Yi Ke Da Xue Xue Bao. 2012 Jun;32(6):890-3.
Title: [Therapeutic effect of axitinib and 5-FU in nude mice bearing human colon cancer xenograft].
Author: Zhao, Jia|Zhao, Ting|Xie, Fengwei|He, Benfu
PMID: 22699078
Journal: PLoS One. 2012;7(8):e41763.
Title: Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
Author: Zhu, Ming Ming|Tong, Jin Lu|Xu, Qi|Nie, Fang|Xu, Xi Tao|Xiao, Shu Dong|Ran, Zhi Hua
PMID: 22870247
Journal: Acta Biochim Pol. 2012;59(4):467-74. Epub 2012 Nov 21.
Title: The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.
Author: Tokarz, Paulina|Blasiak, Janusz
PMID: 23173124
Journal: Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jan;16(1):89-92.
Title: [Effect of 5-fluorouracil on the expression of ATP-binding cassette superfamily G member 2 in human colon cancer cell SW480].
Author: Qu, Jin-miao|You, Jie|Liu, Hai-guang|Huang, Qi-di|Guo, Gui-long
PMID: 23355249
Journal: Eur J Cancer. 2013 May;49(8):2059-64.
Title: Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo.
Author: Lin, Fan|Hoogendijk, Lisette|Buil, Levi|Beijnen, Jos H|van Tellingen, Olaf
PMID: 23422148
Journal: Int J Biol Markers. 2013 Jun 28;28(2):182-6.
Title: Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidence.
Author: Lin, Pei-Ching|Lin, Hung-Hsin|Lin, Jen-Kou|Lin, Chun-Chi|Yang, Shung-Haur|Li, Anna Fen-Yau|Chen, Wei-Shone|Chang, Shih-Ching
PMID: 23558935
Journal: J Mol Med (Berl). 2013 Aug;91(8):989-1000.
Title: MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.
Author: Shen, Wei-Wei|Zeng, Zhi|Zhu, Wen-Xia|Fu, Guo-Hui
PMID: 23619912
Journal: Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jun;16(6):524-8.
Title: [Correlation of MDR1 and ABCG2 genetic polymorphisms with the efficacy and adverse events of irinotecan chemotherapy in patients with colorectal cancer].
Author: Sun, Zhi-wei|Wang, Xi-cheng|Gao, Jing|Li, Jie|Li, Yan-yan|Dang, Yun-zhi|Shen, Lin
PMID: 23801203
Journal: Cancer Biomark. 2013;13(2):81-8.
Title: Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival.
Author: Wang, Xinying|Xia, Bingqing|Liang, Yan|Peng, Liang|Wang, Zhongqiu|Zhuo, Jingwei|Wang, Weifei|Jiang, Bo
PMID: 23838136
Journal: Mol Cancer Ther. 2013 Oct;12(10):2121-34.
Title: Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pump.
Author: Mazard, Thibault|Causse, Annick|Simony, Joelle|Leconet, Wilhem|Vezzio-Vie, Nadia|Torro, Adeline|Jarlier, Marta|Evrard, Alexandre|Del Rio, Maguy|Assenat, Eric|Martineau, Pierre|Ychou, Marc|Robert, Bruno|Gongora, Celine
PMID: 23960095
Journal: PLoS One. 2013 Sep 4;8(9):e72843.
Title: Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.
Author: Giampieri, Riccardo|Scartozzi, Mario|Loretelli, Cristian|Piva, Francesco|Mandolesi, Alessandra|Lezoche, Giovanni|Del Prete, Michela|Bittoni, Alessandro|Faloppi, Luca|Bianconi, Maristella|Cecchini, Luca|Guerrieri, Mario|Bearzi, Italo|Cascinu, Stefano
PMID: 24023782
Journal: J Pharm Sci. 2013 Dec;102(12):4444-54.
Title: Bitter melon extracts enhance the activity of chemotherapeutic agents through the modulation of multiple drug resistance.
Author: Kwatra, Deep|Venugopal, Anand|Standing, David|Ponnurangam, Sivapriya|Dhar, Animesh|Mitra, Ashim|Anant, Shrikant
PMID: 24129966
Journal: Oncol Res. 2013;21(1):51-7.
Title: In vitro characterization of stem cell-like properties of drug-resistant colon cancer subline.
Author: Yang, Dong|Wang, Haijuan|Zhang, Jinlong|Li, Chunxiao|Lu, Zhong|Liu, Jin|Lin, Chen|Li, Guixin|Qian, Haili
PMID: 24330852
Journal: Mol Med Rep. 2014 Jan;9(1):261-6.
Title: Pien Tze Huang suppresses the stem-like side population in colorectal cancer cells.
Author: Wei, Lihui|Chen, Pangyu|Chen, Youqin|Shen, Aling|Chen, Hongwei|Lin, Wei|Hong, Zhenfeng|Sferra, Thomas J|Peng, Jun
PMID: 24173665
Journal: Ann Oncol. 2014 Feb;25(2):398-403.
Title: Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study.
Author: Custodio, A|Moreno-Rubio, J|Aparicio, J|Gallego-Plazas, J|Yaya, R|Maurel, J|Higuera, O|Burgos, E|Ramos, D|Calatrava, A|Andrada, E|Lopez, R|Moreno, V|Madero, R|Cejas, P|Feliu, J
PMID: 24351404
Journal: Sci Rep. 2014 Apr 30;4:4852.
Title: Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer.
Author: Yasunaga, Masahiro|Matsumura, Yasuhiro
PMID: 24781822
Journal: Int J Oncol. 2014 Sep;45(3):1175-83.
Title: Characterization of side population cells isolated from the colon cancer cell line SW480.
Author: Xiong, Binghong|Ma, Li|Hu, Xiang|Zhang, Caiquan|Cheng, Yong
PMID: 24926880
Journal: Invest New Drugs. 2014 Oct;32(5):893-903.
Title: Resistance mechanisms of cancer cells to the novel vacuolar H(+)-ATPase inhibitor archazolid B.
Author: Hamm, Rebecca|Sugimoto, Yoshikazu|Steinmetz, Heinrich|Efferth, Thomas
PMID: 25065443
Journal: J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 15;969:213-8.
Title: Development and validation of an ultra-high performance LC-MS/MS assay for intracellular SN-38 in human solid tumour cell lines: comparison with a validated HPLC-fluorescence method.
Author: Ghazaly, Essam|Perry, Jackie|Kitromilidou, Christiana|Powles, Thomas|Joel, Simon
PMID: 25195021
Journal: Int J Mol Sci. 2014 Sep 5;15(9):15767-77.
Title: CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen.
Author: Silvestris, Nicola|Simone, Giovanni|Partipilo, Giulia|Scarpi, Emanuela|Lorusso, Vito|Brunetti, Anna Elisabetta|Maiello, Evaristo|Paradiso, Angelo|Mangia, Anita
PMID: 25198900
Journal: PLoS One. 2014 Sep 16;9(9):e107158.
Title: The sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by Nrf2 silencing.
Author: Choi, Bo-hyun|Ryoo, In-geun|Kang, Han Chang|Kwak, Mi-Kyoung
PMID: 25226504
Journal: Oncol Res Treat. 2014;37(11):666-8, 670-2.
Title: ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
Author: Xie, Zheng-Yuan|Lv, Ke|Xiong, Ying|Guo, Wu-Hua
PMID: 25427584
Journal: Evid Based Complement Alternat Med. 2014;2014:679436.
Title: Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-beta Pathway.
Author: Shen, Aling|Chen, Hongwei|Chen, Youqin|Lin, Jiumao|Lin, Wei|Liu, Liya|Sferra, Thomas J|Peng, Jun
PMID: 25505925
Journal: Biomed Rep. 2015 Jan;3(1):105-109.
Title: Investigation of the functional single-nucleotide polymorphisms in the BCRP transporter and susceptibility to colorectal cancer.
Author: Sari, Fatih M|Yanar, Hakan T|Ozhan, Gul
PMID: 25469257
Journal: Genes Nutr. 2015 Jan;10(1):448.
Title: Interactions between meat intake and genetic variation in relation to colorectal cancer.
Author: Andersen, Vibeke|Vogel, Ulla
PMID: 25491747
Journal: Mol Pharmacol. 2015;87(3):465-76.
Title: The c-MET/PI3K signaling is associated with cancer resistance to doxorubicin and photodynamic therapy by elevating BCRP/ABCG2 expression.
Author: Jung, Kyeong-Ah|Choi, Bo-Hyun|Kwak, Mi-Kyoung
PMID: 25534417
Journal: Bioorg Med Chem. 2015 Feb 1;23(3):602-11.
Title: IND-2, a pyrimido[1'',2'':1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.
Author: Karthikeyan, Chandrabose|Lee, Crystal|Moore, Joshua|Mittal, Roopali|Suswam, Esther A|Abbott, Kodye L|Pondugula, Satyanarayana R|Manne, Upender|Narayanan, Narayanan K|Trivedi, Piyush|Tiwari, Amit K
PMID: 25537531
Journal: Pharm Res. 2015 Jul;32(7):2205-16.
Title: Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1).
Author: Kort, Anita|Durmus, Selvi|Sparidans, Rolf W|Wagenaar, Els|Beijnen, Jos H|Schinkel, Alfred H
PMID: 25563977
Journal: Cancer Chemother Pharmacol. 2015 Apr;75(4):763-72.
Title: Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy.
Author: Joerger, M|Huitema, A D R|Boot, H|Cats, A|Doodeman, V D|Smits, P H M|Vainchtein, L|Rosing, H|Meijerman, I|Zueger, M|Meulendijks, D|Cerny, T D|Beijnen, J H|Schellens, J H M
PMID: 25677447
Journal: PLoS One. 2015 Mar 20;10(3):e0119255.
Title: High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.
Author: Andersen, Vibeke|Vogel, Lotte K|Kopp, Tine Iskov|Saebo, Mona|Nonboe, Annika W|Hamfjord, Julian|Kure, Elin H|Vogel, Ulla
PMID: 25793771
Journal: Mol Cancer. 2015 Apr 28;14:92.
Title: FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance.
Author: Westover, David|Ling, Xiang|Lam, Hong|Welch, Jacob|Jin, Chunyang|Gongora, Celine|Del Rio, Maguy|Wani, Mansukh|Li, Fengzhi
PMID: 25928015
Journal: Biochem Biophys Res Commun. 2015 Jul 31;463(3):229-34.
Title: Chemoresistance of CD133(+) colon cancer may be related with increased survivin expression.
Author: Lee, Mi-Ra|Ji, Sun-Young|Mia-Jan, Khalilullah|Cho, Mee-Yon
PMID: 26002465
Journal: Sci Rep. 2015 May 28;5:10357.
Title: Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer.
Author: Cioffi, Michele|D'Alterio, Crescenzo|Camerlingo, Rosalba|Tirino, Virginia|Consales, Claudia|Riccio, Anna|Ierano, Caterina|Cecere, Sabrina Chiara|Losito, Nunzia Simona|Greggi, Stefano|Pignata, Sandro|Pirozzi, Giuseppe|Scala, Stefania
PMID: 26020117
Journal: Scand J Gastroenterol. 2015;50(12):1469-81.
Title: Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.
Author: Kopp, Tine Iskov|Andersen, Vibeke|Tjonneland, Anne|Vogel, Ulla
PMID: 26109419
Journal: Cancer Biol Ther. 2015;16(10):1438-44.
Title: Prognostic impact of membranous ATP-binding cassette Sub-family G member 2 expression in patients with colorectal carcinoma after surgical resection.
Author: Kang, Donghoon|Park, Jae Myung|Jung, Chan Kwon|Lee, Bo-In|Oh, Seong Taek|Choi, Myung-Gyu
PMID: 26176272
Journal: PLoS One. 2015 Jul 17;10(7):e0132977.
Title: Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Author: Alberti, Loredana|Losi, Lorena|Leyvraz, Serge|Benhattar, Jean
PMID: 26185996
Journal: Biochem Pharmacol. 2015 Sep 1;97(1):27-37.
Title: Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
Author: To, Kenneth K W|Poon, Daniel C|Wei, Yuming|Wang, Fang|Lin, Ge|Fu, Li-wu
PMID: 26206183
Journal: Biomed Pharmacother. 2015 Aug;74:49-56.
Title: Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines.
Author: Wojtowicz, Karolina|Januchowski, Radoslaw|Nowicki, Michal|Zabel, Maciej
PMID: 26349962
Journal: Exp Cell Res. 2015 Nov 1;338(2):222-31.
Title: Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
Author: To, Kenneth K W|Leung, W W|Ng, Simon S M
PMID: 26386386
Journal: Oncol Rep. 2015 Dec;34(6):2943-52.
Title: OCT4B1 promotes cell growth, migration and invasion suppressing sensitivity to omicronxaliplatin in colon cancer.
Author: Wen, Kun-Ming|Zhang, Gui-Hai|Li, Jiang|Chen, Zheng-Quan|Cheng, Yi-Lin|Su, Xuan|Zeng, Qing-Liang
PMID: 26398480
Journal: J Cancer. 2015 Sep 3;6(11):1079-86.
Title: ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer.
Author: Trumpi, K|Emmink, B L|Prins, A M|van Oijen, M G H|van Diest, P J|Punt, C J A|Koopman, M|Kranenburg, O|Rinkes, I H M Borel
PMID: 26516354
Journal: World J Gastroenterol. 2015 Nov 7;21(41):11862-76.
Title: Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Author: Andersen, Vibeke|Svenningsen, Katrine|Knudsen, Lina Almind|Hansen, Axel Kornerup|Holmskov, Uffe|Stensballe, Allan|Vogel, Ulla
PMID: 26557010
Journal: Exp Ther Med. 2015 Nov;10(5):1845-1850.
Title: Hedyotis diffusa Willd overcomes 5-fluorouracil resistance in human colorectal cancer HCT-8/5-FU cells by downregulating the expression of P-glycoprotein and ATP-binding casette subfamily G member 2.
Author: Li, Qiongyu|Wang, Xiangfeng|Shen, Aling|Zhang, Yuchen|Chen, Youqin|Sferra, Thomas J|Lin, Jiumao|Peng, Jun
PMID: 26640560
Journal: Cell Death Differ. 2016 Apr;23(4):707-22.
Title: DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53.
Author: Alam, S K|Yadav, V K|Bajaj, S|Datta, A|Dutta, S K|Bhattacharyya, M|Bhattacharya, S|Debnath, S|Roy, S|Boardman, L A|Smyrk, T C|Molina, J R|Chakrabarti, S|Chowdhury, S|Mukhopadhyay, D|Roychoudhury, S
PMID: 26494468
Journal: Oncol Rep. 2016 Jan;35(1):298-306.
Title: Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines.
Author: Moon, Hyun-Hye|Kim, Sung-Hee|Ku, Ja-Lok
PMID: 26497773
Journal: J Cell Biochem. 2016 Jun;117(6):1471-81.
Title: Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-kappaB Pathway in Colorectal Cancer.
Author: Sui, Hua|Zhou, Li-Hong|Zhang, Ya-Li|Huang, Jian-Ping|Liu, Xuan|Ji, Qing|Fu, Xiao-Ling|Wen, Hao-Tian|Chen, Zhe-Sheng|Deng, Wan-Li|Zhu, Hui-Rong|Li, Qi
PMID: 26590365
Journal: Cancer Chemother Pharmacol. 2016 Mar;77(3):613-21.
Title: Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription.
Author: Ye, Pingjiang|Xing, Haibo|Lou, Fang|Wang, Kaifeng|Pan, Qin|Zhou, Xiaoyun|Gong, Liu|Li, Da
PMID: 26846508
Journal: Nucleic Acid Ther. 2016 Apr;26(2):111-7.
Title: Lack of Interactions Between an Antisense Oligonucleotide with 2'-O-(2-Methoxyethyl) Modifications and Major Drug Transporters.
Author: Yu, Rosie Z|Warren, Mark S|Watanabe, Tanya|Nichols, Brandon|Jahic, Mirza|Huang, Jane|Burkey, Jennifer|Geary, Richard S|Henry, Scott P|Wang, Yanfeng
PMID: 26959999
Journal: Cancer Lett. 2016 Jun 28;376(1):118-26.
Title: Pyrimido[1'',2'':1,5]pyrazolo[3,4-b]quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells.
Author: Karthikeyan, Chandrabose|Malla, Ritu|Ashby, Charles R Jr|Amawi, Haneen|Abbott, Kodye L|Moore, Joshua|Chen, Joel|Balch, Curt|Lee, Crystal|Flannery, Patrick C|Trivedi, Piyush|Faridi, Jesika S|Pondugula, Satyanarayana R|Tiwari, Amit K
PMID: 27012188
Journal: Data Brief. 2016 Mar 2;7:437-44.
Title: Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer.
Author: To, Kenneth K W|Poon, Daniel C|Wei, Yuming|Wang, Fang|Lin, Ge|Fu, Li-Wu
PMID: 27014726
Journal: Endocrine. 2016 Aug;53(2):443-52.
Title: SIRT1 prevents hyperuricemia via the PGC-1alpha/PPARgamma-ABCG2 pathway.
Author: Wang, Juan|Zhu, Xiao-Xia|Liu, Lei|Xue, Yu|Yang, Xue|Zou, He-Jian
PMID: 27022940
Journal: Sheng Li Xue Bao. 2016 Apr 25;68(2):171-8.
Title: [c-Myc regulation of ATP-binding cassette transporter reverses chemoresistance in CD133(+) colon cancer stem cells].
Author: Zhang, Huan-Le|Wang, Ping|Lu, Miao-Zhen|Zhang, San-Dian
PMID: 27108904
Journal: Asian Pac J Cancer Prev. 2016;17(4):2271-5.
Title: 5-Aminolevulinic Acid Fluorescence in Detection of Peritoneal Metastases.
Author: Yonemura, Yutaka|Canbay, Emel|Ishibashi, Haruaki|Nishino, Eisei|Endou, Yoshio|Sako, Shouzou|Ogura, Shun-Ichirou
PMID: 27221929
Journal: Sci Rep. 2016 Jun 3;6:26997.
Title: Antibody validation and scoring guidelines for ABCG2 immunohistochemical staining in formalin-fixed paraffin-embedded colon cancer tissue.
Author: Cederbye, Camilla Natasha|Palshof, Jesper Andreas|Hansen, Tine Plato|Duun-Henriksen, Anne Katrine|Linnemann, Dorte|Stenvang, Jan|Nielsen, Dorte Lisbet|Brunner, Nils|Viuff, Birgitte Martine
PMID: 27257141
Journal: Biomed Pharmacother. 2016 Jul;81:38-47.
Title: Drug membrane transporters and CYP3A4 are affected by hypericin, hyperforin or aristoforin in colon adenocarcinoma cells.
Author: Semelakova, M|Jendzelovsky, R|Fedorocko, P
PMID: 27261575
Journal: Tumour Biol. 2016 Sep;37(9):12889-12896.
Title: ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Author: Ma, Lijun|Liu, Ting|Jin, Yiran|Wei, Jun|Yang, Yinxue|Zhang, Hongquan
PMID: 27449042
Journal: Oncol Lett. 2016 Oct;12(4):2752-2760.
Title: ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan.
Author: Tuy, Hoang Dinh|Shiomi, Hisanori|Mukaisho, Ken Ichi|Naka, Shigeyuki|Shimizu, Tomoharu|Sonoda, Hiromichi|Mekata, Eiji|Endo, Yoshihiro|Kurumi, Yoshimasa|Sugihara, Hiroyuki|Tani, Masaji|Tani, Tohru
PMID: 27698852
Journal: Cancer Sci. 2016 Dec;107(12):1776-1784.
Title: Wnt-beta-catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer.
Author: Kobayashi, Minoru|Funayama, Ryo|Ohnuma, Shinobu|Unno, Michiaki|Nakayama, Keiko
PMID: 27709738
Journal: Int J Oncol. 2016 Dec;49(6):2558-2568.
Title: Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
Author: El Khoury, Flaria|Corcos, Laurent|Durand, Stephanie|Simon, Brigitte|Le Jossic-Corcos, Catherine
PMID: 27748801
Journal: Stem Cell Res Ther. 2016 Dec 1;7(1):181.
Title: Bile acid: a potential inducer of colon cancer stem cells.
Author: Farhana, Lulu|Nangia-Makker, Pratima|Arbit, Evan|Shango, Kathren|Sarkar, Sarah|Mahmud, Hamidah|Hadden, Timothy|Yu, Yingjie|Majumdar, Adhip P N
PMID: 27908290
Journal: Mol Carcinog. 2017 Feb;56(2):464-477.
Title: A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development.
Author: To, Kenneth K W|Leung, Wing W|Ng, Simon S M
PMID: 27253631
Journal: Oncotarget. 2017 Apr 25;8(17):28463-28470.
Title: Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes.
Author: Hu, Jun|Li, Jian|Yue, Xin|Wang, Jiacang|Liu, Jianzhong|Sun, Lin|Kong, Dalu
PMID: 28212529
Journal: J Cell Commun Signal. 2017 Mar;11(1):79-87.
Title: What roles do colon stem cells and gap junctions play in the left and right location of origin of colorectal cancers?
Author: Trosko, James E|Lenz, Heinz-Josef
PMID: 28220297
Journal: PeerJ. 2017 Feb 15;5:e3003.
Title: Risk analysis of colorectal cancer incidence by gene expression analysis.
Author: Shangkuan, Wei-Chuan|Lin, Hung-Che|Chang, Yu-Tien|Jian, Chen-En|Fan, Hueng-Chuen|Chen, Kang-Hua|Liu, Ya-Fang|Hsu, Huan-Ming|Chou, Hsiu-Ling|Yao, Chung-Tay|Chu, Chi-Ming|Su, Sui-Lung|Chang, Chi-Wen
PMID: 28229027
Journal: Breast Cancer Res Treat. 2017 Jun;163(3):461-474.
Title: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
Author: Asaduzzaman, Muhammad|Constantinou, Stephanie|Min, Haoxiang|Gallon, John|Lin, Meng-Lay|Singh, Poonam|Raguz, Selina|Ali, Simak|Shousha, Sami|Coombes, R Charles|Lam, Eric W-F|Hu, Yunhui|Yague, Ernesto
PMID: 28341962
Journal: J Huazhong Univ Sci Technolog Med Sci. 2017 Apr;37(2):231-236.
Title: Targeting BCRP/ABCG2 by RNA interference enhances the chemotherapy sensitivity of human colon cancer side population cells.
Author: Hu, Jun|Li, Jian|Yue, Xin|Wang, Jia-Cang|Wang, Jun-Feng|Liu, Jian-Zhong|Kong, Da-Lu
PMID: 28397046
Journal: Sci Rep. 2017 Jun 9;7(1):3182.
Title: Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity.
Author: Sonowal, Himangshu|Pal, Pabitra B|Wen, Jian-Jun|Awasthi, Sanjay|Ramana, Kota V|Srivastava, Satish K
PMID: 28600556
Journal: Tumour Biol. 2017 Jun;39(6):1010428317715155.
Title: Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/beta-catenin-ABCG2 signaling pathway in ALDHA1(+) colorectal cancer stem cells.
Author: Chen, Binghe|Zhang, Dezhong|Kuai, Jun|Cheng, Mingkun|Fang, Xiangjie|Li, Guangyan
PMID: 28639895
Journal: Oncol Rep. 2017 Oct;38(4):2293-2300.
Title: Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.
Author: Lin, Jiumao|Feng, Jianyu|Yang, Hong|Yan, Zhaokun|Li, Qiongyu|Wei, Lihui|Lai, Zijun|Jin, Yiyi|Peng, Jun
PMID: 28849113
Journal: Int J Mol Sci. 2017 Sep 7;18(9). pii: ijms18091926.
Title: Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review.
Author: Nielsen, Dorte Lisbet|Palshof, Jesper Andreas|Brunner, Nils|Stenvang, Jan|Viuff, Birgitte Martine
PMID: 28880238
Journal: Prog Biomater. 2017 Dec;6(4):137-145.
Title: SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells.
Author: Nagheh, Zahra|Irani, Shiva|Mirfakhraie, Reza|Dinarvand, Rassoul
PMID: 28948511
Journal: Cancer Biol Ther. 2017 Dec 2;18(12):974-983.
Title: LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.
Author: Hu, Baoli|Zhang, Haifeng|Wang, Zuopei|Zhang, Feng|Wei, Haitao|Li, Li
PMID: 29020498
Journal: Oncotarget. 2017 Dec 14;8(70):115803-115816.
Title: Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/beta-catenin signaling.
Author: Zhang, Kun|Li, Minhui|Huang, Houyi|Li, Linpeng|Yang, Jie|Feng, Li|Gou, Junjie|Jiang, Mengju|Peng, Liaotian|Chen, Linyi|Li, Ting|Yang, Ping|Yang, Yuhan|Wang, Yuanyuan|Peng, Quekun|Dai, Xiaozhen|Zhang, Tao
PMID: 29383202
Journal: J Cell Physiol. 2018 Jun;233(6):5034-5043.
Title: Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
Author: Xu, Juan|Wu, Jiacong|Fu, Chenyang|Teng, Fang|Liu, Siyu|Dai, Chencheng|Shen, Rong|Jia, Xuemei
PMID: 29219179
Journal: J Cell Physiol. 2018 Jul;233(7):5458-5467.
Title: Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
Author: Hsu, Hsi-Hsien|Chen, Ming-Cheng|Baskaran, Rathinasamy|Lin, Yueh-Min|Day, Cecilia H|Lin, Yi-Jiun|Tu, Chuan-Chou|Vijaya Padma, Viswanadha|Kuo, Wei-Wen|Huang, Chih-Yang
PMID: 29247488
Journal: Curr Med Chem. 2018 Jan 4. pii: CMC-EPUB-87731.
Title: ABC transporters: Regulation and association with multidrug resistance in hepatocellular carcinoma and colorectal carcinoma.
Author: Ceballos, Maria Paula|Rigalli, Juan Pablo|Cere, Lucila Ines|Semeniuk, Mariana|Catania, Viviana Alicia|Ruiz, Maria Laura
PMID: 29303075
Journal: Environ Toxicol. 2018 May;33(5):587-593.
Title: Lupeol alters ER stress-signaling pathway by downregulating ABCG2 expression to induce Oxaliplatin-resistant LoVo colorectal cancer cell apoptosis.
Author: Chen, Ming-Cheng|Hsu, Hsi-Hsien|Chu, Yuan-Yuan|Cheng, Sue-Fei|Shen, Chia-Yao|Lin, Yi-Jiun|Chen, Ray-Jade|Viswanadha, Vijaya Padma|Lin, Yueh-Min|Huang, Chih-Yang
PMID: 29436100
Journal: Drug Metab Dispos. 2018 May;46(5):636-642.
Title: Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity.
Author: Eclov, Rachel J|Kim, Mee J|Smith, Robin|Ahituv, Nadav|Kroetz, Deanna L
PMID: 29467213
Journal: Mol Cell Biochem. 2018 Apr 11. pii: 10.1007/s11010-018-3346-4.
Title: Effects of increased accumulation of doxorubicin due to emodin on efflux transporter and LRP1 expression in lung adenocarcinoma and colorectal carcinoma cells.
Author: Iyer, Vidhya V|Priya, P Yoga|Kangeyavelu, Jeipreeti
PMID: 29644529
Journal: Oncol Rep. 2018 Jun;39(6):2881-2891.
Title: Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells.
Author: Alowaidi, Faisal|Hashimi, Saeed Mujahid|Alqurashi, Naif|Alhulais, Reem|Ivanovski, Saso|Bellette, Bernadette|Meedenyia, Adrian|Lam, Alfred|Wood, Stephen
PMID: 29693155
Journal: J Agric Food Chem. 2018 May 23;66(20):5190-5199.
Title: Reversal Effects of Bound Polyphenol from Foxtail Millet Bran on Multidrug Resistance in Human HCT-8/Fu Colorectal Cancer Cell.
Author: Lu, Yang|Shan, Shuhua|Li, Hanqing|Shi, Jiangying|Zhang, Xiaoli|Li, Zhuoyu
PMID: 29730933
Journal: Clin Lab. 2018 Mar 1;64(3):311-319.
Title: Upregulation of Breast Cancer Resistance Protein Expression was Decreased in Plasma Membrane of Colon Cancer with Metastasis of Lymphatic Node.
Author: Wu, Ao|Zhang, Jiaoli|Zeng, Liyan|Li, Feng|Dong, Zhaoguang|Feng, Yanling|Jia, Xiaofang|Jin, Jun-O|Zhang, Lijun
PMID: 29739115
Journal: Mol Med Rep. 2018 Aug;18(2):1323-1334.
Title: Salvianolic acid B reverses multidrug resistance in nude mice bearing human colon cancer stem cells.
Author: Guo, Piaoting|Wang, Jianchao|Gao, Wencang|Liu, Xia|Wu, Shaofei|Wan, Boshun|Xu, Lei|Li, Yanhua
PMID: 29845279
Journal: Int J Biol Macromol. 2018 Oct 1;117:445-453.
Title: Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.
Author: Jin, Yinghu|Wang, Meng|Hu, Hanqing|Huang, Quanlong|Chen, Yinggang|Wang, Guiyu
PMID: 29852230
Journal: Photodiagnosis Photodyn Ther. 2018 Sep;23:221-229.
Title: Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer.
Author: Khot, M Ibrahim|Perry, Sarah L|Maisey, Thomas|Armstrong, Gemma|Andrew, Helen|Hughes, Thomas A|Kapur, Nikil|Jayne, David G
PMID: 29969677
Journal: Oncol Rep. 2018 Oct;40(4):2137-2146.
Title: Protective role of ABCG2 against oxidative stress in colorectal cancer and its potential underlying mechanism.
Author: Nie, Shuang|Huang, Yaqing|Shi, Mengyue|Qian, Xuetian|Li, Hongzhen|Peng, Chunyan|Kong, Bo|Zou, Xiaoping|Shen, Shanshan
PMID: 30066914
Journal: Cancers (Basel). 2018 Sep 4;10(9). pii: cancers10090308.
Title: Cariprazine, A Dopamine D(2)/D(3) Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer.
Author: Hussein, Noor|Ashby, Charles R Jr|Amawi, Haneen|Nyinawabera, Angelique|Vij, Atul|Khare, Vishwa M|Karthikeyan, Chandrabose|Tiwari, Amit K
PMID: 30181510
Journal: Pharmacol Res. 2018 Sep 11;136:133-139.
Title: Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.
Author: Salvador-Martin, Sara|Garcia-Gonzalez, Xandra|Garcia, Maria I|Blanco, Carolina|Garcia-Alfonso, Pilar|Robles, Luis|Gravalos, Cristina|Pachon, Vanessa|Longo, Federico|Martinez, Virginia|Sanjurjo-Saez, Maria|Lopez-Fernandez, Luis A
PMID: 30213564